chrX-155027041-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_023934.4(FUNDC2):āc.103A>Cā(p.Lys35Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000354 in 1,191,440 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 123 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_023934.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FUNDC2 | NM_023934.4 | c.103A>C | p.Lys35Gln | missense_variant | 1/5 | ENST00000369498.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FUNDC2 | ENST00000369498.8 | c.103A>C | p.Lys35Gln | missense_variant | 1/5 | 1 | NM_023934.4 | P1 | |
FUNDC2 | ENST00000475165.5 | n.242+361A>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000242 AC: 27AN: 111549Hom.: 0 Cov.: 23 AF XY: 0.000148 AC XY: 5AN XY: 33769
GnomAD3 exomes AF: 0.000280 AC: 42AN: 150114Hom.: 0 AF XY: 0.000273 AC XY: 12AN XY: 43928
GnomAD4 exome AF: 0.000366 AC: 395AN: 1079844Hom.: 0 Cov.: 31 AF XY: 0.000339 AC XY: 118AN XY: 348558
GnomAD4 genome AF: 0.000242 AC: 27AN: 111596Hom.: 0 Cov.: 23 AF XY: 0.000148 AC XY: 5AN XY: 33826
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.103A>C (p.K35Q) alteration is located in exon 1 (coding exon 1) of the FUNDC2 gene. This alteration results from a A to C substitution at nucleotide position 103, causing the lysine (K) at amino acid position 35 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at